Development of a urinary riboflavin adherence marker for a wheat bran fiber community intervention trial

Geriatric rehabilitation has to be evaluated by cost-effectiveness measures and not only by effectiveness. This is also true for quality improvement actions. Quality can be too expensive according to its cost-effectiveness relationship. In Germany mandatory nursing insurance share in successful rehabilitation means a loss of financial resources to the nursing family members and to the nursing homes. The health funds which have to finance the rehabilitation are also not favored by the results. So rehabilitation is on a low level in the mandatory nursing insurance. Helpful would be to transfer rehabilitation from the health funds to the nursing funds. In the long run geriatric rehabilitation will win importance by the socio-demographic development.     

An evaluation of dual-energy X-Ray absorptiometry and underwater weighing to estimate body composition by means of carcass analysis in piglets

To evaluate the use of dual-energy X-ray absorptiometry (DXA) and underwater weighing (UWW) for body-composition measurements, the carcasses of eight piglets (12-wk old, 15-22 kg in weight) were dissected into muscle, fat and bone. Thereafter, the components were homogenized and chemically analyzed for fat and bone mineral mass. Body components as measured by DXA correlated closely to the carcass analysis (r = 0.90-1.0). However, DXA still overestimated significantly the bone mineral mass, lean mass and total weight, and underestimated fat mass. The reproducibility of measurements, expressed as the CV for fat mass was 13.5%, whereas for total weight, lean mass and bone mineral mass, the CV was 0.74-1.9%. Fat mass was overestimated by UWW using the equations of Siri or Kraybill (r = 0. 77), but not by the equation of Lohman et al. (r = 0.69). The difference between the estimation of fat by chemical analysis and estimations by DXA and UWW was significantly affected by the amount of water in lean mass and fat-free mass.     

Direct measurement of brain temperature during and after intraischemic hypothermia: correlation with behavioral, physiological, and histological endpoints

The aim of the present study was to evaluate critically the protection afforded by hypothermia against ischemic injury to the hippocampus. Hypothermic treatment was applied selectively to the brain during a 5 min carotid artery occlusion in gerbils. Following a period of recovery, two independent measures were used to assess hippocampal function: (1) an open field test of spatial memory (assessment was made during the first 10 d after ischemia) and (2) measurement of evoked potentials from area CA1 in hippocampal slices (3 weeks after the ischemic episode). The functional outcome portrayed by these tests was compared to a morphological evaluation of CA1 pyramidal cells at three rostrocaudal levels. All evaluations were carried out in the same animals. We found converging evidence that intraischemic hypothermia provides virtually complete protection against a 5 min episode of cerebral ischemia. Animals treated with hypothermia performed as well as sham-operated controls in a spatial memory task, had field potentials that were indistinguishable from normal animals and CA1 cells appeared normal when assessed histologically. In contrast, ischemia at normothermia resulted in a deficit in open field behavior (p < 0.01), diminished field potentials in stratum radiatum (p < 0.01), and near total loss of pyramidal cells in dorsal CA1 (p < 0.01). There was a remarkably high correlation between these diverse measures (r ranged from 0.7 to 0.9, p < 0.01), which provides strong support for the use of hypothermia as an effective treatment for ischemia. This study introduces a novel approach for the evaluation of putative anti-ischemic treatments: combining behavioral, electrophysiological, and histological measures.(ABSTRACT TRUNCATED AT 250 WORDS)     

Identifying true lidocaine allergy

Allergies to local anesthetics are rare. More often, the allergic response is caused by a metabolite, preservative or unrelated substance. At times, an apparent allergic reaction can be brought on by anxiety. An idiopathic reaction to lidocaine is described, and allergy testing is discussed.     

Experimental model of lead nephropathy. III. Continuous low-level lead administration

Currently used systems for red blood cell (RBC) collection and storage for transfusion have the disadvantage that the RBC 2,3-bisphosphoglycerate (BPG) concentration is depleted within two weeks of storage, resulting in a left-shift of the oxygen dissociation curve and a temporarily impaired capacity to deliver oxygen. We have studied the effects on red cell metabolism, morphology and in vivo recovery of 49-day storage of RBC, with collection in half-strength citrate CPD (0.5CPD) and storage in an additive solution containing citrate, adenine, mannitol, phosphate and glucose (RAS2). Traditional CPD-SAGM was used for comparison. Component preparation was performed after an initial holding period of the whole blood at ambient temperature for 8 h. The BPG concentration in 0.5CPD-RAS2 RBC was 0.633 +/- 0.120 mol (mol Hb)-1 as compared to 0.454 +/- 0.138 mol (mol Hb)-1 in CPD-SAGM RBC which implied a decrease to 67 and 48% of normal concentration, respectively. The mean RBC BPG concentration was maintained at the initial level for 28 days in the new system but decreased to very low levels within 14 days in the controls. The total adenine nucleotides were well maintained in both systems, adenosine triphosphate slightly better in the new system. Hemolysis after 49 days was 0.35 +/- 0.21% in the new system and 0.72 +/- 0.25% in the controls (p < 0.001). The morphology was better maintained in the new system (p < 0.001). The 24-hour posttransfusion survival of 49-day stored RBC was 78.9 +/- 7.1%. The membrane leakage of sodium and potassium was not significantly different in the two systems.(ABSTRACT TRUNCATED AT 250 WORDS)     

Treatment of lung metastases from malignant melanoma with IL-2 inhalation therapy

Seven patients with pulmonary metastases of malignant melanoma were treated with inhalation therapy with 36 million IU interleukin-2 for six months. Inhalation therapy was combined with four bolus infusions of DTIC at a dose of 850 mg/m2 once every four weeks. Response rates were 71.4% with 2 patients achieving a complete remission (CR), 2 partial remissions (PR), 1 stable disease (SD), and 2 progressing disease (PD). Therapy was well tolerated with low toxicity. Six of the patients developed cough; one patient was slightly feverish. We conclude that inhalation therapy of lung metastases is a promising addition to the therapeutic arsenal against malignant melanoma.